Initial Treatment and Cost of Care in Pulmonary HypertensionA new study finds that the first treatment chosen to treat PAH may help mitigate the burden of all-cause cost of care.
Breast Cancer, Chemotherapy, & HF: The Long-term Effects of EpirubicinHow do the benefits of epirubicin against breast cancer stack up against the risk of late-onset heart failure?
ECG Features Predict 30-day Arrhythmias in Older Adults with SyncopeA new study identified 6 ECG features that warn of potentially fatal cardiac arrhythmia in adults presenting with syncope.
Apolipoprotein(a): What Role in Atrial Fibrillation?Is elevated Lp(a) a risk factor for ischemic stroke in persons with atrial fibrillation? Results of this ARIC analysis explain.
Chlorthalidone: Under-appreciated, Under-utilized, UndervaluedChlorthalidone is one of the "Rodney Dangerfield" diuretics in the treatment of hypertension. That needs to change.
2017 ACC/AHA Hypertension Guidelines: The TakeawaysClick through our topline review of the key takeaways from this long-awaited update.
The Top 5 Biomarkers in Cardiovascular Disease PreventionWhich biomarker is most useful in what situation? Find out how one cardiologist makes these decisions. Do you concur?
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
5 Stubborn Statin Myths vs Data that Refute ThemAt AHA.17, Dr Rory Collins offered large-scale trial data to help dispel dangerous disinformation still circulating about the effects of statins.
2017 ACC/AHA Hypertension Guidelines: Case StudyClick through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.